Occudo Quantitative Strategies’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History
Bought
Maintained
Sold
Other funds holding OCDX
CG
VI
SCM
MF
Occudo Quantitative Strategies's OCDX Position: Q1 2022 in Review
Occudo Quantitative Strategies sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q1 2022, closing a stake of 22,814 shares — an estimated $488K sold.
Occudo Quantitative Strategies first reported a position in OCDX in Q2 2021 and held it in 3 quarters. The position peaked at $1.29M in Q3 2021. 170 funds tracked by Wall St. Rank hold OCDX as of Q1 2022.
- Occudo Quantitative Strategies reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q1 2022 after selling out during the quarter.
- Occudo Quantitative Strategies sold 22,814 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q1 2022, an estimated $488K.
- Occudo Quantitative Strategies first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2021 and held it in 3 quarters.
- Occudo Quantitative Strategies's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $1.29M in Q3 2021.
- 170 funds tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q1 2022.
Based on Occudo Quantitative Strategies's 13F filing for Q1 2022, filed 16 May 2022.